Clinical Trial

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Study acronym: Iron-RANC
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an open-label, single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-03-24; most recent amendment 2026-05-20.
Trial Details
NCT Number NCT05800600
Lead Sponsor Fox Chase Cancer Center
Conditions Anemia
Enrollment 34 participants
Start Date 2023-03-15
Primary Completion 2027-02-01 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-22